CELL BIOTECHNOLOGY GROUP INC.
Home
About Us
Corporate Introduction
Cooperation & Communication
Social Mission
Company Events
Research Project
Cell Treatment Research
Service Support
Technical Expert
Management Team
Trade News
Updated Information
Industry Trends
Testimonials
Market
Research
Testimonials
Contact Us
Cell Treatment Research
Cell Treatment Research
AllogeneicMesenchymalPrecursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose Escalation Safety and Tolerability Pilot Study
DateandTime：2022-06-27 13:15:57 | Hits：379
AllogeneicMesenchymalPrecursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled,
Dose Escalation Safety and Tolerability Pilot Study
©2022 CELL BIOTECHNOLOGY GROUP INC. All Rights Reserved Tel：+1-647-4090807
CELL BIOTECHNOLOGY GROUP INC.